Our research strategy builds on the university’s recognised strengths and will leverage centres of excellence across the university. We will focus on a translational approach to healthcare research that is directly relevant to the cancers that most affect our local population.
Our research approach will be driven by data, including different types of research and experts from a diverse range of fields, with the focus being on problems relevant to our population. We will work together to ensure that we address all aspects of cancer research from prevention to screening, diagnosis, drug discovery and treatment, follow-up, palliation and survival.
Our research themes
We will use a data-driven, problem-based approach toward a platform of multimodal cancer research and treatments, outlined in our cross-cutting, interrelated research themes.
Cancer prevention and early diagnosis
Theme Lead: Professor Nicholas Latimer
The research within the theme of cancer prevention and early diagnosis will describe and analyse the characteristics and outcomes of cancers experienced in the Yorkshire population. The vision is that through gaining a better understanding of Yorkshire’s cancers, targeted interventions and screening programmes can be developed to improve survival, primarily through earlier diagnosis.
Digital health, big data, advanced diagnostic technologies and rethinking the delivery of cancer care
Theme Lead: Professor Jim Catto
Our research will integrate modern technology and digital health with re-envisaging the delivery of cancer care. The vision for research within this theme is that digital healthcare information, artificial intelligence and more intelligent use of novel diagnostics in clinical pathways will increase the volume and safety of community-based oncology treatments. We will use digital technology to inform risk profiles.
The aim is that this will improve patient experience and save NHS costs.
Translational and precision cancer medicine
Theme Lead: Dr Munitta Muthana
Our research will integrate genomic profiling within the patient’s cancer journey, from the initial suspicion of cancer through clinical investigations, diagnosis and treatment. Genomic profiling can predict how cancers will grow and which treatments might work best for an individual.
We will reveal insights into the role and opportunities of modern genomics in cancer care, offer patients the opportunity to take part in the next generation of pharmaceutical studies and feed into molecular research in the University.
Improving the outcomes for cancer patients – reducing mortality and exploring experience and value
Theme Leads: Professor Sarah Danson and Professor Ingunn Holen
The vision for our research within this theme is to better understand what matters to our patients, to discover new treatments or better ways of giving current treatments as well as develop a new methodology for matching treatment to patients’ individual cancers.
The University of Sheffield Vice President for Research, Professor Sue Hartley, chairs the University of Sheffield Cancer Research Oversight Board which oversees the development of the cancer research strategy across the university, its alignment with the university strategy for research and innovation and the institution's utilisation of strategic funding.
The Board comprises the Vice Presidents for all five of the University's faculties, alongside the Deputy Vice President for Innovation, the Commercial Director and the Research Growth Officer for Cancer Research.